Perjeta Chemotherapy Information
If you have breast cancer, your healthcare provider may prescribe PerjetaTM (pertuzumab). This medicine is specifically approved for use in adults, and must be used in combination with certain other medications. Perjeta is designed to treat breast cancer that has spread to other areas of the body (metastasized) and that expresses a specific type of protein on the cancer cells.
Perjeta is given as an intravenous (IV) infusion. A healthcare provider will administer the medicine in a healthcare setting, such as a hospital. This medication is usually given once every three weeks.
Before receiving Perjeta, make sure to review the medication's safety information with your healthcare provider. Unlike many other cancer treatments that are a type of chemotherapy, Perjeta is a biologic therapy. It is less "toxic" than chemotherapy, as it specifically targets certain receptors on the cancer cells. Because it is only used to treat cancers that have a high concentration of these receptors, it targets the tumors, having less of an effect on healthy, noncancerous cells.
(Click Perjeta for more information on this medication, including why it is not a form of chemotherapy and what to expect during treatment.)